Corporate Profile's CPreports.com Publishes Article by RAY DIRKS of RAY DIRKS Research on Tanke Biosciences
20 June 2012 - 10:00PM
Marketwired
Corporate Profile's financial website www.CPreports.com announces
Ray Dirks article on Tanke Biosciences Corp. (OTCBB: TNBI) (OTCQB:
TNBI)
To view article go to: www.CPReports.com or
http://www.cpreports.com/?p=2130
About CPreports.com CPreports.com features
Ray Dirks, Gene Marcial, and Rob Goldman. The website and
newsletter provide readers and subscribers fresh, original, and
highly informative ideas and market commentary that they won't get
anywhere else. Content is focused on what is going on in the stock
market and on Wall Street.
About Corporate Profile.com
www.CorporateProfile.com is a broadcasting website where Fashion
meets Finance, merging two mainstream industries results in the
unique platform for today's hottest tips and market info.
About Ray Dirks Research Ray Dirks came to
Wall Street with Goldman, Sachs & Co. in 1963 where he was
established as the leading insurance stock analyst dealing with
institutional investors and high-net worth investors both in the
U.S. and internationally. Ray's research includes Healthcare Stocks
and Special Situations. Ray has written two books, "The Great Wall
Street Scandal" and "Heads You Win, Tails You Win," published by
McGraw-Hill and Bantam Books respectively. He continues to provide
research to institutions and individuals. Ray can be reached at:
rdirks@nyc.rr.com
Safe Harbor Disclaimer Under The Private Securities Litigation
Reform Act of 1995: Except for historical information contained
herein, the statements in this news release are forward-looking
statements that are made pursuant to the safe harbor provisions of
the Private Securities Act of 1995. Forward-looking statements
involve known and unknown risks and uncertainties, which may cause
a company's actual results, performance and achievement in the
future to differ materially from forecasted results, performance,
and achievement. These risks and uncertainties are described in the
Company's periodic filings with the Securities and Exchange
Commission. The Company undertakes no obligation to publicly
release the results of any revisions to these forward-looking
statements that may be made to reflect events or circumstances
after the date hereof, or to reflect the occurrence of
unanticipated events or changes in the Company's plans or
expectation.
Tanke Biosciences (PK) (USOTC:TNBI)
Historical Stock Chart
From Jan 2025 to Feb 2025
Tanke Biosciences (PK) (USOTC:TNBI)
Historical Stock Chart
From Feb 2024 to Feb 2025
Real-Time news about Tanke Biosciences Corporation (PK) (OTCMarkets): 0 recent articles
More Corporate Profile LLC News Articles